All Industry News articles – Page 5
-
NewsResearchers awarded €1.2 million to commercialise cultivated meat
Companies have received €1.2 million in additional funding from EIT Food to develop innovative products to reduce the cost of producing cultivated meat within the next two years.
-
NewsE coli bacteria engineered to generate electricity from wastewater
Scientists have reported a groundbreaking achievement in bioelectronics, advancing the capabilities of common E. coli bacteria to generate electricity.
-
CareersFungi-produced silver nanoparticles could be useful for wound healing
Scientists have synthesized silver nanoparticles using fungi, mainly of the genus Fusarium.
-
NewsHuman milk-based synbiotic safely modulates damaged adult gut microbiomes
Bacteria found in the gut of nursing infants, combined with certain sugars from human milk, may enable ‘precision microbiome engineering’ as live biotherapeutics.
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAcademic-private partnership aims to reduce toxic effects of deadly C. diff
The Center for One Health Research and Nectagen Inc. have received a nearly $275,000 grant to study whether synthetic proteins developed by Nectagen can reduce the toxicity of the digestive bacterium.
-
NewsBiotech spinoff PHIOGEN to tackle threat of antimicrobial resistance
A new biotech spin-off, PHIOGEN, has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections.
-
NewsSpinout to develop 20-minute test following STI surge in UK
A University of Birmingham spinout has received funding to finesse a point-of-care test for rapid diagnosis of gonorrhoea and chlamydia in men who have sex with men, and women who have sex with women.
-
NewsPlant and microbial innovation hub in Norwich gets green light
Funding has been confirmed for the development of a ground-breaking plant and microbial science and innovation hub, providing world-class facilities for the John Innes Centre (JIC) and The Sainsbury Laboratory (TSL).
-
NewsTeam founds AI-powered vaccine library to prevent future pandemics
A research project to develop novel antigen designs will focus on 10 known virus families to build the ‘vaccine library’, using the computer-based Rosetta platform.
-
NewsNEC Society launches neonatal probiotics toolkit
The Necrotizing Enterocolitis (NEC) Society has released a toolkit that provides structure to clinicians in neonatal intensive care units (NICUs) as they consider the complex process and decision of whether to implement probiotics to help prevent NEC.
-
NewsReichman University announces new Scojen Institute for Synthetic Biology
A new research institute for the development of cutting-edge technologies in the field of synthetic biology is to be set up, acting as a hub for interdisciplinary research.
-
NewsUK launches 10-year science strategy to save lives and boost prosperity
The UK Health Security Agency (UKHSA) has launched a ten-year Science Strategy, setting out how UKHSA’s science can save more lives, secure health and prosperity and contribute to the UK’s ambition to be a global science superpower.
-
NewsWarning over lack of ‘substantial evidence’ for FDA approved antibiotic
Drugs approved in the US require “substantial evidence” that they are effective, but an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
-
NewsAntibiotics should be halted upon incision closure
New guidelines: antibiotics administered before and during surgery should be discontinued immediately after a patient’s incision is closed, according to updated recommendations for preventing surgical site infections.
-
NewsMonoclonal antibody programme targets mucormycosis
Vitalex Biosciences has been awarded an SBIR Phase 2 grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health for VX-01, a monoclonal antibody (mAB) programme targeting the debilitating indication of the fungal disease, mucormycosis.
-
NewsEuropean-funded €2.3m project will revolutionize bioprinting of living materials
The PRISM-LT project has received a €2.3 million grant for a five-year program that aims to create an adaptable platform for 3D bioprinting of living tissue with dynamic functionalities and predictable shapes.
-
NewsDr Rob Turner appointed as General Manager of Wickham Micro
Wickham Micro, a leading UK provider of microbiology testing services, has announced the appointment of Dr. Rob Turner as the new General Manager, as part of the company’s ongoing investment strategy to drive growth and innovation.
-
NewsWHO warns of dearth of new antibiotics, especially those targeting drug-resistant pathogens
A review from WHO on the number of new antibiotics currently in the pipeline shows that just 12 new antibiotics have entered the market in the five years from 2017-21.
-
NewsIntellifoods Labs, LLC teams with Mason scientists to cut food bacterial contamination detection time
Mason Associate Professor of Infectious Diseases and Microbiology, Ramin M Hakami has received $35,000 in grants from Intellifoods Labs, LLC to continue examining methods to reduce the time to detect the presence of bacteria in food samples.